Innovus Pharma Announces the Approval of the Product Licenses; Zestra, Zestra Glide, EjectDelay, Sensum+ by the Indian FDA Through Its Partner Khandelwal Laboratories
Innovus Pharmaceuticals, Inc. ("Innovus Pharma") (OTCQB Venture Market:INNV), an emerging commercial stage cash flow positive pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men and women's health and respiratory diseases, today announced today that its partner Khandelwal Laboratories received the approval of the product licenses for Zestra®, Zestra Glide®, EjectDelay® and Sensum+® from the Indian FDA, The Drugs Controller General (India), and the Directorate General of Health Services to commercialize the products...
View full press release